How to buy SeqLL stock (SeqLL)

SeqLL is a diagnostics & research business based in the US. SeqLL shares (SQL) are listed on the NASDAQ and all prices are listed in US Dollars. SeqLL employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy SeqLL stock

Buy SeqLL stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

SeqLL stock price (NASDAQ: SQL)

Use our graph to track the performance of SQL stocks over time.

SeqLL shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$3.20 - $5.09
50-day moving average more info button	$11.63
200-day moving average more info button	$15.77
Wall St. target price	$3.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-16.40

Is it a good time to buy SeqLL stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SeqLL financials

Gross profit TTM	$77,969
Return on assets TTM	-40%
Return on equity TTM	-113.72%
Profit margin	0%
Book value	$8.40
Market Capitalization more info button	$2.6 million

TTM: trailing 12 months

SeqLL share dividends

We're not expecting SeqLL to pay a dividend over the next 12 months.

You may also wish to consider:

• Qiagen (QGEN.US) (2.94% forward annual dividend yield)

Have SeqLL's shares ever split?

SeqLL's shares were split on a 1:40 basis on 30 August 2023 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SeqLL shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for SeqLL shares which in turn could have impacted SeqLL's share price.

SeqLL share price volatility

Over the last 12 months, SeqLL's shares have ranged in value from as little as $3.2 up to $5.0875. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SeqLL's is 1.342. This would suggest that SeqLL's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put SeqLL's beta into context you can compare it against those of similar companies.

• Pacific Biosciences of California (PACB.US): 2.009
• Qiagen (QGEN.US): 0.404
• Illumina (ILMN.US): 1.131

SeqLL overview

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U. S.

Frequently asked questions

What percentage of SeqLL is owned by insiders or institutions?
Currently 31.497% of SeqLL shares are held by insiders and 7.312% by institutions. How many people work for SeqLL?
Latest data suggests 7 work at SeqLL. When does the fiscal year end for SeqLL?
SeqLL's fiscal year ends in December. Where is SeqLL based?
SeqLL's address is: 3 Federal Street, Billerica, MA, United States, 01821 What is SeqLL's ISIN number?
SeqLL's international securities identification number is: US81734C1062